Silver halide photographic materials
    2.
    发明授权
    Silver halide photographic materials 失效
    卤化银照相材料

    公开(公告)号:US4596766A

    公开(公告)日:1986-06-24

    申请号:US658742

    申请日:1984-10-09

    CPC分类号: G03C1/385 G03C1/895

    摘要: A silver halide photographic material is disclosed comprising a support having thereon at least one layer containing a nonionic surface active agent having a polyoxyethylene group and a fluorine-containing compound, wherein the element composition of the surface of said layer has a ratio of F.sub.ls peak intensity/C.sub.ls peak intensity in the range of 0.3 to 2.0 when measured by an X-ray photoelectron spectrometry.

    摘要翻译: 公开了一种卤化银照相材料,其包含其上具有至少一层含有聚氧乙烯基和含氟化合物的非离子表面活性剂的载体的载体,其中所述层的表面的元素组成具有Fls峰强度 / Cls峰强度在0.3〜2.0的范围内,通过X射线光电子能谱测定。

    Optical members, and processes, compositions and polymers for preparing them
    3.
    发明申请
    Optical members, and processes, compositions and polymers for preparing them 审中-公开
    光学部件和工艺,用于制备它们的组合物和聚合物

    公开(公告)号:US20060173148A1

    公开(公告)日:2006-08-03

    申请号:US10526381

    申请日:2003-09-04

    IPC分类号: C08F118/02

    摘要: Novel optical members formed of a polymer comprising a repeating unit derived from a polymerizable monomer (A) which is a methacrylate derivative having a branched C3-8 alkyl group or a repeating unit derived from a polymerizable monomer (3) which is a (meth)acrylate derivative having a C7-20 alicyclic hydrocarbon group are disclosed. Novel processes for preparing an optical member comprising polymerization of a composition comprising the monomer (A) or the monomer (3) are also disclosed.

    摘要翻译: 由包含衍生自具有支链C 3-8烷基的甲基丙烯酸酯衍生物的可聚合单体(A)的重复单元或由可聚合单体(3)衍生的作为(甲基)丙烯酸酯的聚合性单体的聚合物形成的新型光学部件, 丙烯酸酯衍生物,具有C7-20脂环族烃基。 还公开了制备含有单体(A)或单体(3)的组合物的聚合的光学构件的新方法。

    Optical members and compositions for producing them
    4.
    发明申请
    Optical members and compositions for producing them 有权
    用于制造它们的光学构件和组合物

    公开(公告)号:US20060056786A1

    公开(公告)日:2006-03-16

    申请号:US10531704

    申请日:2003-11-14

    IPC分类号: G02B6/028

    CPC分类号: G02B1/045 C08F2/44 G02B1/041

    摘要: It is disclosed a polymerizable composition for producing an optical member for 850 nm wavelength comprising: a polymerizable monomer composition and a compound, having a different refractive index from that of the polymerizable monomer composition, whose structure has a benzene ring substituted by a substituent having a Hammett value of not greater than 0.04 or by plural substituents having an average value of Hammett values thereof of not greater than 0.04. It is also disclosed a polymerizable composition for producing an optical member comprising a polymerizable monomer composition comprising at least one selected from the group consisting of C7-20 alicyclic (meth) acrylates and a compound, having a different refractive index from that of the polymerizable monomer composition and having a solubility parameter of not greater than 10.9, whose structure has a benzene ring substituted by the substituent or the substituents defined above.

    摘要翻译: 公开了一种用于制造850nm波长的光学部件的可聚合组合物,包括:可聚合单体组合物和具有与可聚合单体组合物的折射率不同的折射率的化合物,其结构具有被具有 哈米特值不大于0.04,或由哈米特值的平均值不大于0.04的多个取代基组成。 还公开了一种用于制造光学部件的可聚合组合物,其包含可聚合单体组合物,其包含选自由C 7-20脂环族(甲基)丙烯酸酯组成的组中的至少一种和具有不同的 折射率与可聚合单体组合物的折射率相差并且具有不大于10.9的溶解度参数,其结构具有由取代基或上述取代基取代的苯环。

    Method for judging effectiveness of drug having protease inhibitory activity
    5.
    发明授权
    Method for judging effectiveness of drug having protease inhibitory activity 有权
    评估具有蛋白酶抑制活性的药物有效性的方法

    公开(公告)号:US06413734B1

    公开(公告)日:2002-07-02

    申请号:US09641349

    申请日:2000-08-18

    IPC分类号: C12Q137

    摘要: A method for judging effectiveness of a drug having protease inhibitory activity, which comprises the steps of: (1) bringing a biosample isolated or collected from a patient with a disease in which participation of a protease is suspected into contact with a thin membrane containing a protease substrate and formed on a surface of a support; (2) detecting a trace of digestion formed on the thin membrane by action of a protease; and (3) judging that a drug having protease inhibitory activity is effective for the patient when a trace of digestion is formed on the thin membrane. The method enables accurate judgment as to whether or not a drug having protease inhibitory activity is effective for a patient with a disease in which participation of a protease is suspected such as rheumatoid arthritis and cancer before administration of the drug.

    摘要翻译: 一种用于判断具有蛋白酶抑制活性的药物的有效性的方法,其包括以下步骤:(1)将患有蛋白酶参与的患者分离或收集的生物样品与含有蛋白酶抑制活性的薄膜接触的疾病 蛋白酶底物并形成在支撑体的表面上; (2)通过蛋白酶的作用检测在薄膜上形成的消化痕迹; 和(3)当在薄膜上形成消化痕迹时,判断具有蛋白酶抑制活性的药物对患者有效。 该方法能够准确判断具有蛋白酶抑制活性的药物是否有疑似患有蛋白酶参与的疾病的患者,例如类风湿性关节炎和药物给药前的癌症。

    CASEIN NANOPARTICLE
    6.
    发明申请
    CASEIN NANOPARTICLE 审中-公开

    公开(公告)号:US20090280148A1

    公开(公告)日:2009-11-12

    申请号:US12295287

    申请日:2007-03-29

    摘要: An object of the present invention to provide: a nanoparticle, which can be produced without the use of surfactants and synthetic polymers, which has a controllable size and is stable in the acidic range, and which further contains an active substance; and a method for producing the same. The present invention provides a casein nanoparticle which contains an active substance and has an average particle size between 10 nm or more and less than 300 nm, which is produced by the following steps (a) to (c): (a) a step of mixing casein into a basic aqueous medium between pH 8 or more and less than pH 11; (b) a step of adding at least one type of active substance to the solution obtained in the step (a); and (c) a step of injecting the solution obtained in the step (b) into an acidic aqueous medium at pH 3.5 to pH 7.5.

    摘要翻译: 本发明的目的是提供:纳米颗粒,其可以不使用表面活性剂和合成聚合物来制造,其具有可控的尺寸并且在酸性范围内是稳定的,并且还含有活性物质; 及其制造方法。 本发明提供一种含有活性物质并具有10nm以上且小于300nm的平均粒径的酪蛋白纳米颗粒,其通过以下步骤(a)至(c)制备:(a)步骤 将酪蛋白混合在pH8以上且小于pH11之间的碱性水性介质中; (b)向步骤(a)获得的溶液中加入至少一种活性物质的步骤; 和(c)将步骤(b)中得到的溶液注入pH 3.5至pH7.5的酸性水性介质中的步骤。

    Optical members and compositions for producing them
    7.
    发明授权
    Optical members and compositions for producing them 有权
    用于制造它们的光学构件和组合物

    公开(公告)号:US07343073B2

    公开(公告)日:2008-03-11

    申请号:US10531704

    申请日:2003-11-14

    IPC分类号: G02B6/028

    CPC分类号: G02B1/045 C08F2/44 G02B1/041

    摘要: It is disclosed a polymerizable composition for producing an optical member for 850 nm wavelength comprising: a polymerizable monomer composition and a compound, having a different refractive index from that of the polymerizable monomer composition, whose structure has a benzene ring substituted by a substituent having a Hammett value of not greater than 0.04 or by plural substituents having an average value of Hammett values thereof of not greater than 0.04. It is also disclosed a polymerizable composition for producing an optical member comprising a polymerizable monomer composition comprising at least one selected from the group consisting of C7-20 alicyclic (meth)acrylates and a compound, having a different refractive index from that of the polymerizable monomer composition and having a solubility parameter of not greater than 10.9, whose structure has a benzene ring substituted by the substituent or the substituents defined above.

    摘要翻译: 公开了一种用于制造850nm波长的光学部件的可聚合组合物,包括:可聚合单体组合物和具有与可聚合单体组合物的折射率不同的折射率的化合物,其结构具有被具有 哈米特值不大于0.04,或由哈米特值的平均值不大于0.04的多个取代基组成。 还公开了一种用于制造光学部件的可聚合组合物,其包含可聚合单体组合物,其包含选自由C 7-20脂环族(甲基)丙烯酸酯组成的组中的至少一种和具有不同的 折射率与可聚合单体组合物的折射率相差并且具有不大于10.9的溶解度参数,其结构具有由取代基或上述取代基取代的苯环。

    Silver halide emulsion containing a thiocyanate compound having specific
absorbance in IR spectroscopy
    9.
    发明授权
    Silver halide emulsion containing a thiocyanate compound having specific absorbance in IR spectroscopy 失效
    含有在IR光谱中具有特定吸光度的硫氰酸酯化合物的卤化银乳剂

    公开(公告)号:US4921784A

    公开(公告)日:1990-05-01

    申请号:US886052

    申请日:1986-07-16

    CPC分类号: G03C1/09 G03C1/005

    摘要: A thiocyanate-containing silver halide emulsion, characterized in that a disc tablet of 2.5 mm in diameter formed of 10 mg of silver halide contained in the silver halide emulsion shows an absorbance of 0.015 or higher or thiocyanate ion at 2052 cm.sup.-1, measured by IR spectroscopy. The emulsion is high in sensitivity, small in loss of photographic sensitivity caused by pressure and small in fluctuations in results of photographic processings.

    摘要翻译: 一种含硫氰酸盐的卤化银乳剂,其特征在于,由卤化银乳剂中所含的10mg卤化银形成的直径2.5mm的圆盘片剂在2052cm -1处显示出0.015或更高的吸光度或硫氰酸根离子,其通过 红外光谱。 乳液的灵敏度高,摄影敏感性降低,摄影处理结果波动较小。